Promotion of Neuronal Plasticity by (−)-Epigallocatechin-3-Gallate

被引:0
|
作者
Wen Xie
Narayan Ramakrishna
Andrzej Wieraszko
Yu-Wen Hwang
机构
[1] City University of New York,CSI/IBR Center for Developmental Neuroscience, College of Staten Island
[2] City University of New York,Doctoral Program in Biology, The Graduate Center
[3] College of Staten Island,Department of Biology
[4] New York State Institute for Basic Research in Developmental Disabilities,Molecular Biology Department
来源
Neurochemical Research | 2008年 / 33卷
关键词
LTP; EGCG; Ts65Dn mouse; Down syndrome animal model; Paired-pulse inhibition; Tea catechins; Hippocampal slices;
D O I
暂无
中图分类号
学科分类号
摘要
The consumption of (−)-epigallocatechin-3-gallate (EGCG), the major polyphenolic compound found in green tea, has been associated with various neurological benefits including cognitive improvement. The physiological basis for this effect is unknown. In this study, we used synaptic transmission between the CA3 and CA1 regions (Schaffer collateral) of the mouse hippocampus to examine the effects of EGCG on neuronal plasticity. We found that the level of high frequency stimulation-evoked long-term potentiation (LTP) was significantly enhanced when hippocampal slices were pre-incubated with 10 μM EGCG for 1 h prior to the experiment. EGCG incubation also enabled hippocampal slices prepared from Ts65Dn mice, a Down syndrome mouse model deficient in LTP, to express LTP to a level comparable to the normal controls. EGCG treatment did not alter the degree of pair-pulse inhibition; therefore, the enhancement effect of EGCG is unlikely to involve the attenuation of this inhibitory mechanism.
引用
收藏
页码:776 / 783
页数:7
相关论文
共 50 条
  • [1] Promotion of neuronal plasticity by (-)-epigallocatechin-3-gallate
    Xie, Wen
    Ramakrishna, Narayan
    Wieraszko, Andrzej
    Hwang, Yu-Wen
    NEUROCHEMICAL RESEARCH, 2008, 33 (05) : 776 - 783
  • [2] Epigallocatechin and epigallocatechin-3-gallate are not inhibitors of tyrosinase
    Gasowska-Bajger, Beata
    Wojtasek, Hubert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 113
  • [3] Fibrosis modulation in scleroderma by epigallocatechin-3-gallate
    Kocak, A.
    Harmanci, D.
    Birlik, M.
    Sarioglu, S.
    Yilmaz, O.
    Cavdar, Z.
    Akdogan, G. Guner
    FEBS JOURNAL, 2017, 284 : 123 - 123
  • [4] Antifibrotic properties of epigallocatechin-3-gallate in endometriosis
    Matsuzaki, Sachiko
    Darcha, Claude
    HUMAN REPRODUCTION, 2014, 29 (08) : 1677 - 1687
  • [5] TLC separation of methylated (-)-epigallocatechin-3-gallate
    Amarowicz, R
    Maryniak, A
    Shahidi, F
    CZECH JOURNAL OF FOOD SCIENCES, 2005, 23 (01) : 36 - 39
  • [6] The Effect of (-)-Epigallocatechin-3-Gallate on the Aβ Secondary Structure
    Acharya, Atanu
    Stockmann, Julia
    Beyer, Leon
    Nabers, Andreas
    Gerwert, Klaus
    Gumbart, James C.
    Batista, Victor S.
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 47A - 47A
  • [7] Antioxidant Nanocomplexes for Delivery of Epigallocatechin-3-gallate
    Hu, Bing
    Ma, Fengguang
    Yang, Yingkang
    Xie, Minhao
    Zhang, Chen
    Xu, Ye
    Zeng, Xiaoxiong
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2016, 64 (17) : 3422 - 3429
  • [8] Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
    Cheong, Yucheol
    Kim, Minjin
    Ahn, Jina
    Oh, Hana
    Lim, Jongkwan
    Chae, Wonil
    Yang, Seung Won
    Kim, Min Seok
    Yu, Ji Eun
    Byun, Sanguine
    Jang, Yo Han
    Seong, Baik Lin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Assessment of safety and embryotoxicity of (-)-Epigallocatechin-3-gallate
    Rodriguez-Fragoso, Lourdes
    Isabel Gonsaga-Morales, Ana
    Reyes Esparza, Jorge
    FASEB JOURNAL, 2012, 26
  • [10] Topical epigallocatechin-3-gallate in the treatment of vitiligo
    Hu, Wenting
    Zhang, Lingling
    Lin, Fuquan
    Lei, Jiehao
    Zhou, Miaoni
    Xu, AiE
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (03) : E404 - E407